Literature DB >> 3021441

Identification of corticotropin-releasing factor (CRF) target cells and effects of dexamethasone on binding in anterior pituitary using a fluorescent analog of CRF.

J Schwartz, N Billestrup, M Perrin, J Rivier, W Vale.   

Abstract

A fluorescein-conjugated bioactive analog of corticotropin-releasing factor (CRF) was synthesized and used to label cells that have high affinity CRF-binding sites. Of cultured bovine anterior pituitary cells, 6.1 +/- 0.6% were visible by fluorescence microscopy after incubation with the analog. Fluorescence was eliminated by coincubation with a 200-fold excess of unlabeled CRF. Treatment with dexamethasone (10(-9)-10(-7) M) decreased visible fluorescence in a dose-dependent manner. These results demonstrate the utility of a fluorescent CRF analog for identification of cells with specific CRF-binding sites and suggest that binding of CRF to anterior pituitary cells is altered by glucocorticoids.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3021441     DOI: 10.1210/endo-119-5-2376

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  3 in total

1.  Synthesis and characterization of a photoactivatable analog of corticotropin-releasing factor for specific receptor labeling.

Authors:  A Rühmann; A K Köpke; F M Dautzenberg; J Spiess
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-01       Impact factor: 11.205

2.  Evidence for arginine vasopressin as the primary activator of the HPA axis during adjuvant-induced arthritis.

Authors:  H S Chowdrey; P J Larsen; M S Harbuz; D S Jessop; G Aguilera; D J Eckland; S L Lightman
Journal:  Br J Pharmacol       Date:  1995-11       Impact factor: 8.739

3.  miR-449a contributes to glucocorticoid-induced CRF-R1 downregulation in the pituitary during stress.

Authors:  Takahiro Nemoto; Asuka Mano; Tamotsu Shibasaki
Journal:  Mol Endocrinol       Date:  2013-07-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.